TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Canada OKs remdesivir for use against coronavirus

News Desk (Agence France-Presse)
Montreal, Canada
Wed, July 29, 2020 Published on Jul. 29, 2020 Published on 2020-07-29T07:31:17+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Canada OKs remdesivir for use against coronavirus In this file photo taken on April 8, 2020 one vial of the drug remdesivir lies during a press conference about the start of a study with the Ebola drug remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the new coronavirus COVID-19 pandemic.Canada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated with the anti-viral drug remdesivir. (AFP/Ulrich Perrey)

C

anada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated with the anti-viral drug remdesivir.

"Remdesivir is the first drug that Health Canada has authorized for the treatment of COVID-19," said the health ministry.

At least two major US studies have shown that remdesivir can reduce the duration of hospital stays for COVID-19 patients. 

Washington authorized the emergency use of the medicine -- which was originally intended as a treatment for Ebola -- on May 1, followed by several Asian nations including Japan and South Korea.

Canada said Tuesday it can be used on COVID-19 patients who have pneumonia and need extra oxygen to help them breathe.

The doses used in Canada will be made by a unit of Gilead Sciences, the US pharmaceutical company that developed the drug.

In early July, the European Commission also authorized use of remdesivir to treat the coronavirus.

As of Tuesday, Canada was reporting 114,800 cases of the virus and more than 8,900 fatalities.

 

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.